Debt-to-equity of Regen BioPharma Inc from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Regen BioPharma Inc quarterly Debt-to-equity in % history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • Regen BioPharma Inc Debt-to-equity for the quarter ending 31 Dec 2025 was -104%, a 0.46% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Regen BioPharma Inc Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 -104% -0.48% -0.46% 31 Dec 2025
Q3 2025 -104% -0.51% -0.49% 30 Sep 2025
Q2 2025 -103% +0.78% +0.75% 30 Jun 2025
Q1 2025 -103% +1.4% +1.3% 31 Mar 2025
Q4 2024 -103% +2.8% +2.7% 31 Dec 2024
Q3 2024 -103% +4.3% +4% 30 Sep 2024
Q2 2024 -104% +3.3% +3.1% 30 Jun 2024
Q1 2024 -105% +3.3% +3.1% 31 Mar 2024
Q4 2023 -106% -3.6% -3.5% 31 Dec 2023
Q3 2023 -107% -4.8% -4.7% 30 Sep 2023
Q2 2023 -107% -4.3% -4.1% 30 Jun 2023
Q1 2023 -108% -4.3% -4.2% 31 Mar 2023
Q4 2022 -102% +6.4% +5.9% 31 Dec 2022
Q3 2022 -103% +5.6% +5.2% 30 Sep 2022
Q2 2022 -103% +3.2% +3% 30 Jun 2022
Q1 2022 -104% -1.5% -1.5% 31 Mar 2022
Q4 2021 -109% -17% -19% 31 Dec 2021
Q3 2021 -108% -16% -18% 30 Sep 2021
Q2 2021 -106% -14% -15% 30 Jun 2021
Q1 2021 -102% -8.7% -9.3% 31 Mar 2021
Q4 2020 -92% +9% +8.9% 31 Dec 2020
Q3 2020 -92% +9.1% +9% 30 Sep 2020
Q2 2020 -93% +8.8% +8.7% 30 Jun 2020
Q1 2020 -93% +9.5% +9.2% 31 Mar 2020
Q4 2019 -101% +5% +4.8% 31 Dec 2019
Q3 2019 -101% +7.7% +7.1% 30 Sep 2019
Q2 2019 -101% +11% +9.7% 30 Jun 2019
Q1 2019 -103% +14% +12% 31 Mar 2019
Q4 2018 -106% +15% +13% 31 Dec 2018
Q3 2018 -109% +23% +18% 30 Sep 2018
Q2 2018 -112% +34% +23% 30 Jun 2018
Q1 2018 -116% +55% +32% 31 Mar 2018
Q4 2017 -121% +70% +37% 31 Dec 2017
Q3 2017 -132% +39% +23% 30 Sep 2017
Q2 2017 -146% +50% +26% 30 Jun 2017
Q1 2017 -172% +256% +60% 31 Mar 2017
Q4 2016 -191% -500% -162% 31 Dec 2016
Q3 2016 -171% -1399% -114% 30 Sep 2016
Q2 2016 -197% -1901% -112% 30 Jun 2016
Q1 2016 -428% -416% -3468% 31 Mar 2016
Q4 2015 309% +318% 31 Dec 2015
Q3 2015 1228% 30 Sep 2015
Q2 2015 1704% 30 Jun 2015
Q1 2015 -12% 31 Mar 2015
Q4 2014 -8.7% 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.